HOYLE RESPONSE TO THE U.S. SUPREME COURT'S MIFEPRISTONE RULING
June 14, 2024
June 14, 2024
WASHINGTON, June 14 -- Rep. Val Hoyle, D-Oregon, issued the following statement on June 13, 2024:
* * *
Today, U.S. Representative Val Hoyle (OR-04), a proud member of the Congressional Pro-Choice Caucus, issued the following statement after the U.S. Supreme Court released their unanimous ruling on Alliance for Hippocratic Medicine v. FDA, which protected access to FDA-approved abortion medication Mifepristone:
"Today's decision reaffirms that a woman' . . .
* * *
Today, U.S. Representative Val Hoyle (OR-04), a proud member of the Congressional Pro-Choice Caucus, issued the following statement after the U.S. Supreme Court released their unanimous ruling on Alliance for Hippocratic Medicine v. FDA, which protected access to FDA-approved abortion medication Mifepristone:
"Today's decision reaffirms that a woman' . . .